27 February 2025 Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice ...

A game-changer for UPC tech disputes ...

Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner ...

The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function ...

Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...

In Wuhan Healthgen Biotech v ITC, the Federal Circuit affirmed the US International Trade Commission’s (ITC) conclusion that ...

British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent ...

Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.